Niche Expertise Pregistry specializes in drug and vaccine safety during pregnancy, positioning it as a leading partner for pharmaceutical companies seeking specialized post-approval safety studies and regulatory compliance solutions.

Strategic Acquisition The recent acquisition by CorEvitas expands Pregistry’s capabilities and market reach, providing opportunities to leverage broader data sources and deepen client relationships in maternal health monitoring.

Regulatory Focus With a proven track record in observational studies and safety assessments, Pregistry presents an attractive option for pharmaceutical firms aiming to strengthen their safety profiles for pregnancy-related medications and vaccines.

Growth Potential Operating within a high-growth niche of pregnancy safety data, Pregistry's revenue being up to 10 million USD indicates significant market potential and opportunities for tailored solutions for clients expanding in this specialization.

Market Recognition Recognition as a top pregnancy and lactation information platform positions Pregistry as a credible and trusted partner, making it easier to engage pharmaceutical companies invested in maternal health and safety research.